2Kroot EJJA,de Jong BAW,Van Leeuwen MA.et al.The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-on-set rheumatoid arthritis[J].Arthritis Rheum,2000,43(11):1831-1835. 被引量：1
3Menard HA, Lapointe E, Bodadi MA , et al. Insights into rheumatoid arthritis derived from the Sa immunc system. Arthritis Res,2000,2:429 -432. 被引量：1
4Schcllckcns GA, Vissccr H, dc Jong BAW, et al. The diagnostic peperties of rheumatoid arthritis recognizing a cydic citrullinated peptide. Arthritis Rheum,2000,43:155 - 163. 被引量：1
5Kroot EJJA,de Jong BAW, Van Leeuwen MA,et al.The prognostic value of anticylic citrullinated peptide antibody in patients with recent onset rheumatoid arthritis. Arthritis Rheum,2000,43:1 831- 1 835. 被引量：1
6Hassfeld W, Steiner G, Hartmth K,et al. Demonstration of a new antinuclear antibody (anti - RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum, 1989,32:1 515 - 1 520. 被引量：1
1Van der Woude D, Young A, Jayakumar K, et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug- free remission in rheumatoidarthfitis [ J ]. Arthritis Rheum, 2009,60 (8) :2262-2171. 被引量：1
3Aletaha D, Neogi T, Silman A J, et al. 2010 rheumatoid arthritis classi- fication criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative [ J ]. Ann Rheum Dis,2010,69 (9): 1580-1588. 被引量：1
4Barra L, Pope J, Bessette L, et al. Lack of seroconversion of rheuma- toid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review [ J ]. Rheumatolo- gy(Oxford) ,2011,50 (2) :311-316. 被引量：1
